Hepatic Oncology
Volume 7, 2020 - Issue 2
Open access
699
Views
0
CrossRef citations to date
0
Altmetric
Editorial
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
Devis Pascut1 Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149Trieste, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-0583-1973View further author information
, https://orcid.org/0000-0003-0583-1973View further author information
Muhammad Yogi Pratama1 Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149Trieste, Italy;2 Universitas Hasanuddin, Faculty of Medicine, Makassar, 90245, IndonesiaView further author information
& Claudio Tiribelli1 Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149Trieste, Italyhttps://orcid.org/0000-0001-6596-7595View further author information
Article: HEP21
|
Received 31 Mar 2020, Accepted 06 May 2020, Published online: 22 Jun 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.